- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04659473
Spanish Survey on Third Wave of COVID-19
December 10, 2020 updated by: Beatriz-María Bermejo-Gil, University of Salamanca
COVID-19, the Third Wave Update People Coping With the COVID-19. A Cross-sectional Online Spanish Survey
Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping.
Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future contentions plans.
This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic.
The survey will be delivered to 1000 participants to obtain a representative sample.
It would be divided into six sections (general information, demography data, social and consuming habits, Covi-19 question, questions for Covid-19 positive, and questions for Covid-19 negative).
Study Overview
Study Type
Observational
Enrollment (Anticipated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Beatriz M Bermejo-Gil, Professor
- Phone Number: +34 622 289 468
- Email: beatriz.bermejo@usal.es
Study Locations
-
-
-
Salamanca, Spain, 37007
- Universidad de Salamanca
-
Contact:
- Inés Llamas-Ramos, Doctor
- Phone Number: +34 630 720 990
- Email: inesllamas@usal.es
-
Principal Investigator:
- Beatriz M Bermejo-Gil, Professor
-
Sub-Investigator:
- Fátima Pérez-Robledo, Professor
-
Sub-Investigator:
- Rocío Llamas-Ramos, Professor
-
Sub-Investigator:
- Juan L Sánchez-González, Professor
-
Sub-Investigator:
- Inés Llamas-Ramos, Professor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The sample was selected from the Spanish community population
Description
Inclusion Criteria:
- Owning online connection
- Ability to answer and complete the survey
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
What's your work or study system nowadays?
Time Frame: 20 seconds
|
Multiple choice questionnaire
|
20 seconds
|
Habits before the Covid-19 pandemic
Time Frame: 60 seconds
|
Likert scale questionnaire
|
60 seconds
|
Habits in the Covid-19 pandemic
Time Frame: 60 seconds
|
Likert scale questionnaire
|
60 seconds
|
Personal Covid-19 exposure and disease
Time Frame: 10 seconds
|
Dichotomous options questionnaire
|
10 seconds
|
Positive Covid-19: tests, diagnosis, symptoms and quarantine
Time Frame: 60 seconds
|
Multiple choice questionnaire
|
60 seconds
|
Negative Covid-19: tests and quarantine
Time Frame: 40 seconds
|
Multiple choice questionnaire
|
40 seconds
|
Expectations
Time Frame: 10 seconds
|
Multiple choice questionnaire
|
10 seconds
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Date of birth
Time Frame: 20 seconds
|
It is registered in the survey to know the age
|
20 seconds
|
Sex
Time Frame: 20 seconds
|
It is registered in the survey
|
20 seconds
|
Height
Time Frame: 20 seconds
|
It is registered in centimeters
|
20 seconds
|
Weight
Time Frame: 20 seconds
|
It is registered in kilograms
|
20 seconds
|
Blood type
Time Frame: 20 seconds
|
Multiple choice questionnaire
|
20 seconds
|
Pathologic history
Time Frame: 20 seconds
|
Multiple choice questionnaire
|
20 seconds
|
Region of residence
Time Frame: 20 seconds
|
Multiple choice questionnaire
|
20 seconds
|
City of residence
Time Frame: 20 seconds
|
Multiple choice questionnaire
|
20 seconds
|
Rural or urban environment
Time Frame: 20 seconds
|
Dichotomous options questionnaire
|
20 seconds
|
Cohabitants in the family unit
Time Frame: 20 seconds
|
The number of cohabitants is registered in the survey
|
20 seconds
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Beatriz M Bermejo-Gil, Professor, University of Salamanca
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
December 9, 2020
Primary Completion (ANTICIPATED)
December 20, 2020
Study Completion (ANTICIPATED)
December 20, 2020
Study Registration Dates
First Submitted
December 8, 2020
First Submitted That Met QC Criteria
December 8, 2020
First Posted (ACTUAL)
December 9, 2020
Study Record Updates
Last Update Posted (ACTUAL)
December 14, 2020
Last Update Submitted That Met QC Criteria
December 10, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CovidSal01/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Online survey
-
Tomsk National Research Medical Center of the Russian...RecruitingCOVID-19 | Risk Factors | Polypharmacy | Drug Interactions | Self MedicationRussian Federation
-
Jaseng Medical FoundationCompletedFractures, Bone | Medicine, Korean TraditionalKorea, Republic of
-
Hasselt UniversityRecruitingPhysical Activity | Chronic Musculoskeletal Disease | Exercise Intensity | Online SurveyBelgium
-
Virginia Polytechnic Institute and State UniversityNot yet recruitingSubstance Use Disorders
-
Virginia Polytechnic Institute and State UniversityRecruitingAlcohol Use DisorderUnited States
-
Northwestern UniversityEpidermolysis Bullosa Research PartnershipActive, not recruiting
-
University Hospital, GhentCompletedQuality of Life | Mental HealthBelgium
-
Universidad Miguel Hernandez de ElchePontificia Universidad Catolica de Chile; University of Sao Paulo; Universidad... and other collaboratorsCompletedAcute Stress DisorderChile, Argentina, Colombia, Ecuador, Spain
-
University of WashingtonCompletedOnline TherapyUnited States